Compare VF Corp (VFC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VF Corp vs State Street SPDR S&P Biotech ETF — how do they compare? VF Corp trades at $14.78 (market cap $5.81B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: VF Corp pays a 2.44% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, VF Corp nearer its low. Which is the better fit depends on your goals.
| VFC | XBI | |
|---|---|---|
Market Cap | $5.81B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $21.55 | $164.28 |
52-Week Low | $12.21 | $86.92 |
Enterprise Value | $10.09B | — |
Dividend Yield | 2.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
